This document discusses induced lactation from Islamic perspectives, protocols for induced lactation, and the effects of galactogogues. It notes that Islam permits adoptive mothers to induce their own lactation with medical assistance. It describes the Newman Goldfarb Protocol, which uses medications and pumping to induce lactation. It discusses the effects of hormones like prolactin and oxytocin on breast milk production. It provides details on regular, accelerated, and menopause protocols for induced lactation using medications. It also discusses the use of galactogogues like herbs and medications to increase milk supply and notes potential risks and lack of research on many galactagogues.
This document discusses progesterone and its role in female reproduction. It begins by explaining that fertility and menstruation are controlled by hormones, including estrogen and progesterone. Progesterone prepares the uterine lining for pregnancy and supports gestation. Dydrogesterone is then introduced as a synthetic progestogen used to treat gynecological disorders caused by low progesterone levels, such as premenstrual syndrome and recurrent miscarriage. Its mechanism of action, pharmacokinetics, indications, and dosage are described. Finally, a randomized controlled trial is summarized that found dydrogesterone to be as effective as micronized progesterone for luteal support during in vitro fertilization, with the benefit of oral versus vaginal administration.
Role of Dydrogesterone in Threatened Abortion Dr Sharda Jain Lifecare Centre
*EXPERINCE SHARING By EXPERTS*
Dr Uma Rai(DGF *E*)
Dr Sangeetaa Gupta(DGF *E*)
Dr Neerja Varshney(DGF *E*)
Dr Surjeet Kapoor(DGF *E*)
Dr Rupam arora(DGF *E*)
Dr Meenakshi Ahuja(DGF *S* )
Dr.Harsha khullar(DGF *C* )
Dr Mamta mittal(DGF *N*)
Dr Leena Sreedhar(DGF *D*)
Dr.Dipti Nabh(DGF *E*)
Dr. Shama Batra(DGF *E*)
Dr Poonam Paul(DGF *SW*)
PAN DGF ( DELHI GYNAECOLOGIST FORUM) CME ON DYDROGESTERONE ON 3/2 /22
This document summarizes evidence on the use of progesterone to prevent preterm birth. It finds that progesterone reduces the risk of preterm birth before 37 weeks in women with a prior preterm delivery or short cervix. Progesterone may also reduce complications for infants born preterm to mothers receiving it. However, progesterone does not prevent early preterm birth in twin or triplet pregnancies. No long-term harms were seen in children exposed to progesterone prenatally.
Role of Dydrogesterone in Recurrent Pregnancy Loss Dr Sharda Jain Lifecare Centre
Dydrogesterone is commonly used by Indian gynecologists to treat recurrent pregnancy loss. It has higher bioavailability than natural micronized progesterone when taken orally. Dydrogesterone has an immunomodulatory effect that may help prevent miscarriage by inhibiting pro-inflammatory cytokines and increasing anti-inflammatory cytokines and progesterone-induced blocking factor production. It also increases uterine and endometrial blood flow by stimulating nitric oxide production. Several studies and meta-analyses indicate dydrogesterone may be more effective than natural micronized progesterone for treating recurrent pregnancy loss when taken orally, due to its higher bioavailability and specific affinity for progesterone receptors.
This seminar explores the potential connection between two inositol stereoisomers supplements and improvements in insulin sensitivity and various metabolic parameters.
This document discusses the role of progesterone in pregnancy and preventing preterm birth. It begins by outlining the problem of preterm birth globally, noting that 15 million babies are born preterm each year. It then discusses various trials investigating the use of progesterone supplementation to prevent preterm birth, including the large NICHD/MFMU trial which found that weekly injections of 17α-hydroxyprogesterone caproate reduced preterm birth rates. The document also notes vaginal progesterone trials have shown benefits but results are more mixed in high-order multiples and women with a short cervix may benefit most.
1) Luteal phase support is important for assisted reproduction cycles to ensure adequate progesterone levels and proper endometrial development.
2) Progesterone supplementation is generally recommended, with micronized progesterone or dydrogesterone being good options. Vaginal administration is equally effective as intramuscular with fewer side effects.
3) Progesterone should be started 24-48 hours after egg retrieval/release and continued until 9 weeks of pregnancy. The addition of a single GnRH agonist dose may further improve outcomes. hCG is not recommended due to risk of OHSS.
Luteal phase support in ART Cases Dr Sharda Jain Lifecare Centre
The document discusses luteal phase support in assisted reproductive technology (ART) cycles. It provides 3 key points:
1. Luteal phase deficiency is common in ART cycles due to multiple factors like multifollicular development and aspiration of granulosa cells, leading to premature luteolysis and defective progesterone secretion.
2. Progesterone supplementation is important for luteal phase support as progesterone prepares the endometrium, decreases uterine contractility, and regulates immunity - all of which are important for embryo implantation and maintenance of early pregnancy.
3. Oral dydrogesterone is recommended for luteal phase support in ART cycles due to its greater bioavailability allowing the use of lower doses, minimal side effects
This document discusses progesterone and its role in female reproduction. It begins by explaining that fertility and menstruation are controlled by hormones, including estrogen and progesterone. Progesterone prepares the uterine lining for pregnancy and supports gestation. Dydrogesterone is then introduced as a synthetic progestogen used to treat gynecological disorders caused by low progesterone levels, such as premenstrual syndrome and recurrent miscarriage. Its mechanism of action, pharmacokinetics, indications, and dosage are described. Finally, a randomized controlled trial is summarized that found dydrogesterone to be as effective as micronized progesterone for luteal support during in vitro fertilization, with the benefit of oral versus vaginal administration.
Role of Dydrogesterone in Threatened Abortion Dr Sharda Jain Lifecare Centre
*EXPERINCE SHARING By EXPERTS*
Dr Uma Rai(DGF *E*)
Dr Sangeetaa Gupta(DGF *E*)
Dr Neerja Varshney(DGF *E*)
Dr Surjeet Kapoor(DGF *E*)
Dr Rupam arora(DGF *E*)
Dr Meenakshi Ahuja(DGF *S* )
Dr.Harsha khullar(DGF *C* )
Dr Mamta mittal(DGF *N*)
Dr Leena Sreedhar(DGF *D*)
Dr.Dipti Nabh(DGF *E*)
Dr. Shama Batra(DGF *E*)
Dr Poonam Paul(DGF *SW*)
PAN DGF ( DELHI GYNAECOLOGIST FORUM) CME ON DYDROGESTERONE ON 3/2 /22
This document summarizes evidence on the use of progesterone to prevent preterm birth. It finds that progesterone reduces the risk of preterm birth before 37 weeks in women with a prior preterm delivery or short cervix. Progesterone may also reduce complications for infants born preterm to mothers receiving it. However, progesterone does not prevent early preterm birth in twin or triplet pregnancies. No long-term harms were seen in children exposed to progesterone prenatally.
Role of Dydrogesterone in Recurrent Pregnancy Loss Dr Sharda Jain Lifecare Centre
Dydrogesterone is commonly used by Indian gynecologists to treat recurrent pregnancy loss. It has higher bioavailability than natural micronized progesterone when taken orally. Dydrogesterone has an immunomodulatory effect that may help prevent miscarriage by inhibiting pro-inflammatory cytokines and increasing anti-inflammatory cytokines and progesterone-induced blocking factor production. It also increases uterine and endometrial blood flow by stimulating nitric oxide production. Several studies and meta-analyses indicate dydrogesterone may be more effective than natural micronized progesterone for treating recurrent pregnancy loss when taken orally, due to its higher bioavailability and specific affinity for progesterone receptors.
This seminar explores the potential connection between two inositol stereoisomers supplements and improvements in insulin sensitivity and various metabolic parameters.
This document discusses the role of progesterone in pregnancy and preventing preterm birth. It begins by outlining the problem of preterm birth globally, noting that 15 million babies are born preterm each year. It then discusses various trials investigating the use of progesterone supplementation to prevent preterm birth, including the large NICHD/MFMU trial which found that weekly injections of 17α-hydroxyprogesterone caproate reduced preterm birth rates. The document also notes vaginal progesterone trials have shown benefits but results are more mixed in high-order multiples and women with a short cervix may benefit most.
1) Luteal phase support is important for assisted reproduction cycles to ensure adequate progesterone levels and proper endometrial development.
2) Progesterone supplementation is generally recommended, with micronized progesterone or dydrogesterone being good options. Vaginal administration is equally effective as intramuscular with fewer side effects.
3) Progesterone should be started 24-48 hours after egg retrieval/release and continued until 9 weeks of pregnancy. The addition of a single GnRH agonist dose may further improve outcomes. hCG is not recommended due to risk of OHSS.
Luteal phase support in ART Cases Dr Sharda Jain Lifecare Centre
The document discusses luteal phase support in assisted reproductive technology (ART) cycles. It provides 3 key points:
1. Luteal phase deficiency is common in ART cycles due to multiple factors like multifollicular development and aspiration of granulosa cells, leading to premature luteolysis and defective progesterone secretion.
2. Progesterone supplementation is important for luteal phase support as progesterone prepares the endometrium, decreases uterine contractility, and regulates immunity - all of which are important for embryo implantation and maintenance of early pregnancy.
3. Oral dydrogesterone is recommended for luteal phase support in ART cycles due to its greater bioavailability allowing the use of lower doses, minimal side effects
Role of Dydrogesterone in repeated pregnancy lossNiranjan Chavan
Dydrogesterone has been shown to effectively treat recurrent pregnancy loss by modulating the immune system. It shifts the balance from a pro-inflammatory Th1 response towards an anti-inflammatory Th2 response by [1] inhibiting the production of Th1 cytokines IFN-γ and TNF-α and [2] inducing production of the Th2 cytokines IL-4 and IL-6. This results in improved pregnancy outcomes by supporting embryonic development. Clinical studies demonstrate dydrogesterone significantly reduces miscarriage rates in women with recurrent pregnancy loss.
Newer concepts of managing PCOD With Myo-InositolLifecare Centre
Myo-inositol is an effective treatment for polycystic ovary syndrome (PCOS) that works by improving insulin sensitivity and reducing androgen levels. Clinical studies show that myo-inositol reduces testosterone and fasting insulin levels, improves menstrual regularity and ovulation rates, and can help induce pregnancy in women with PCOS. Myo-inositol is a safe and well-tolerated treatment for PCOS that provides metabolic, reproductive, and dermatological benefits without major side effects.
Role of progestogens in obstetrics and gynecologyAhmad Saber
The
different progestogens with their overlapping effects on estrogen, androgen, glucocorticoid,
and mineralocorticoid receptors are described in order to allow the clinician to make the most appropriate choice of progestogen.
Treatment of RPL myths focuses on debunking common misconceptions around recurrent pregnancy loss (RPL). The document discusses several potential causes of RPL including thrombophilia, genetic factors, anatomical abnormalities, endocrine issues, immune factors, and infections. It provides treatment recommendations for different conditions like administering low-dose aspirin and heparin for antiphospholipid syndrome. The effectiveness of progesterone supplementation is questioned based on recent clinical trial results. Surgical and medical management of conditions like chronic endometritis are outlined. The role of various diagnostic tests and treatments for interpreting RPL causes are also examined.
Progesterone, new values in clinical practiceMamdouh Sabry
- Progesterone is a steroid hormone that plays several important roles in the female reproductive system and pregnancy. It can be produced naturally in the body or taken as a synthetic progestin medication.
- There are two major progesterone receptor subtypes, PRA and PRB. PRA inhibits the effects of PRB and other steroid receptors in many tissues where they are expressed.
- Micronized natural progesterone from plant sources has fewer side effects than older synthetic progestins and more closely mimics the body's endogenous progesterone. It can be administered orally, vaginally, or through other routes.
- Progesterone supplementation shows benefits for preventing preterm birth and recurrent pregnancy loss according to some studies,
Dydrogesterone has higher bioavailability (up to 28%) compared to micronized progesterone (less than 10%), allowing it to be effective at a much lower dose of 10-30 mg/day versus 200-300 mg/day for micronized progesterone. Dydrogesterone also causes fewer adverse effects due to its minimal activation of non-progesterone receptors. While dydrogesterone has extensive clinical trial evidence and approvals for threatened miscarriage and progesterone deficiencies, micronized progesterone only has trials and approval for secondary amenorrhea.
This document discusses various methods of contraception, including natural methods, barrier methods, intrauterine devices, implants, injections, oral contraceptives, and emergency contraception. It provides details on the mechanisms of action, effectiveness, and side effects of different hormonal contraceptives containing progestins and/or estrogens, such as combined oral contraceptives, progestin-only pills, contraceptive patches, vaginal rings, and injectables. The document also discusses criteria for use and cautions for different contraceptive methods.
This document discusses various methods for inducing lactation in non-birth mothers, including the use of hormones, galactogogues (medications that increase milk production), herbal supplements, nipple stimulation, and breast pumps. It provides details on hormones involved in lactation, common galactogogues like metoclopramide and domperidone, herbal options like fenugreek and blessed thistle, and the importance of regular nipple stimulation to induce lactation.
Deck on current treatment approaches in endometriosis (PART II) Dr Jyoti AgAR...Lifecare Centre
Dydrogesterone is proposed as a new treatment for endometriosis. It effectively tackles chronic inflammation associated with endometriosis by reducing proinflammatory cytokines and increasing progesterone receptor expression. Clinical evidence shows that dydrogesterone provides symptomatic relief for endometriosis-related pain and improves quality of life. It also reduces the development of new endometriotic lesions and induces atrophy of ectopic endometrial tissue. Unlike other medications, dydrogesterone does not inhibit ovulation or require estrogen add-back therapy, and it may improve pregnancy outcomes for women with endometriosis.
This document discusses luteal phase support in assisted reproductive technology (ART) and recurrent miscarriages. It defines luteal phase defect (LPD) and notes there is no standardized diagnostic test. LPD can cause infertility and recurrent pregnancy loss. Progesterone supplementation is recommended for confirmed LPD, unexplained infertility, advanced maternal age, ART cycles, hyperprolactinemia, and recurrent miscarriages. Progesterone is the preferred drug for luteal phase support as it promotes endometrial development without luteolytic effects. Vaginal progesterone is as effective as intramuscular with fewer side effects and optimal timing and duration of support is from oocyte retrieval/IUI to 9 weeks of gestation.
This document discusses ways to reduce miscarriage rates. It begins by outlining the agenda and introducing progesterone and NIPGT (non-invasive preimplantation genetic testing) as potential approaches. It then discusses how progesterone has immunomodulatory properties and supports the luteal phase in ART cycles. Several studies are summarized that show progesterone supplementation can reduce miscarriage rates. NIPGT is introduced as a less invasive way to assess chromosomal defects in embryos compared to traditional PGT. The document concludes that while progesterone is effective for reducing miscarriage, more evidence is still needed to determine if NIPGT could help in cases of recurrent miscarriage, especially in older patients.
Ovulation induction protocols for unexplained infertility new advances 2019 f...Anu Test Tube Baby Centre
1) Ovulation induction is used to treat unexplained infertility, where no specific cause is identified after basic evaluation. It aims to stimulate ovulation and increase the number of mature follicles available for fertilization.
2) Common protocols for ovulation induction in unexplained infertility include oral medications like clomiphene citrate or letrozole, injectable gonadotropins alone or with GnRH analogues, and IUI with or without ovarian stimulation.
3) While ovulation induction and IUI can help some women with unexplained infertility conceive, success rates decline significantly with increasing female age. Younger patients may benefit from several treatment cycles but many guidelines recommend proceeding directly to IVF after a year if
1) The document reviews the use of GnRH agonists versus HCG for triggering final oocyte maturation in IVF/ICSI cycles using a GnRH antagonist protocol.
2) In fresh autologous cycles, GnRH agonist triggering was found to have lower live birth, ongoing pregnancy rates and higher miscarriage rates compared to HCG, but lower OHSS incidence.
3) In donor-recipient cycles, there was no difference in ongoing pregnancy or miscarriage rates between GnRH agonist and HCG triggering, but GnRH agonists reduced OHSS incidence. Modified luteal phase support strategies have shown mixed results in improving outcomes after GnRH agonist triggering.
My talk on Thyroid and Infertility in Jabalpur in Feb 2019. I have summarised the available evidence until 2019 in an easy to use flowchart and slides. It would be very useful for practicing Endocrinologists, Physicians and Obs-gyn.
Dr. Sunita Chandra is the Chairperson and Director of Rajendra Nagar Hospital & IVF Centre and Director of Morpheus Lucknow Fertility Centre. She has extensive training and experience in fertility and IVF in India and Germany. She has published research papers and book chapters on fertility-related topics. She has held several leadership roles in fertility-related organizations and has spoken at numerous national and international conferences. She has received several awards for her contributions to medicine and healthcare in Uttar Pradesh.
Letrozole is an aromatase inhibitor that is an effective alternative to clomiphene citrate for ovulation induction. It has several advantages over clomiphene citrate including oral administration, lower risk of multiple pregnancies and miscarriage, and no antiestrogenic effects on the endometrium or cervical mucus. Studies show letrozole results in higher ovulation and pregnancy rates compared to clomiphene citrate. When used as an adjuvant to gonadotropins, letrozole reduces gonadotropin dosage and improves outcomes. Letrozole may help improve IVF success rates in poor responders by enhancing follicular response to gonadotropins and lowering estrogen
Ovarian reserve refers to the reproductive potential left within a woman's two ovaries based on number and quality of eggs. Diminished ovarian reserve is the loss of normal reproductive potential in the ovaries due to a lower count or quality of the remaining eggs
Use Of Galactogogues In Initiating Or Augmenting Maternal Milk SupplyBiblioteca Virtual
The document discusses the use of galactogogues, or substances used to induce, maintain, or augment maternal milk production. It provides guidelines for using galactogogues, including evaluating other factors first and increasing breast emptying. The most well-studied galactogogues are metoclopramide and domperidone, which work through dopamine antagonism. Herbal galactogogues like fenugreek are also discussed. Close monitoring of both mother and infant is recommended when using any galactogogue.
This document discusses lactogogues, which are foods or medications that can increase milk production in lactating mothers. It begins by defining lactation and lactose insufficiency. It then describes various types of lactogogues, including the synthetic medications metoclopramide and domperidone, and herbal options like fenugreek, alfalfa, shatavari, and fennel. The document provides details on how these lactogogues work and their potential side effects. It concludes by summarizing a survey that found the most commonly used lactogogues were lactation cookies, brewer's yeast, and fenugreek, and that domperidone had the highest rate of reported
Role of Dydrogesterone in repeated pregnancy lossNiranjan Chavan
Dydrogesterone has been shown to effectively treat recurrent pregnancy loss by modulating the immune system. It shifts the balance from a pro-inflammatory Th1 response towards an anti-inflammatory Th2 response by [1] inhibiting the production of Th1 cytokines IFN-γ and TNF-α and [2] inducing production of the Th2 cytokines IL-4 and IL-6. This results in improved pregnancy outcomes by supporting embryonic development. Clinical studies demonstrate dydrogesterone significantly reduces miscarriage rates in women with recurrent pregnancy loss.
Newer concepts of managing PCOD With Myo-InositolLifecare Centre
Myo-inositol is an effective treatment for polycystic ovary syndrome (PCOS) that works by improving insulin sensitivity and reducing androgen levels. Clinical studies show that myo-inositol reduces testosterone and fasting insulin levels, improves menstrual regularity and ovulation rates, and can help induce pregnancy in women with PCOS. Myo-inositol is a safe and well-tolerated treatment for PCOS that provides metabolic, reproductive, and dermatological benefits without major side effects.
Role of progestogens in obstetrics and gynecologyAhmad Saber
The
different progestogens with their overlapping effects on estrogen, androgen, glucocorticoid,
and mineralocorticoid receptors are described in order to allow the clinician to make the most appropriate choice of progestogen.
Treatment of RPL myths focuses on debunking common misconceptions around recurrent pregnancy loss (RPL). The document discusses several potential causes of RPL including thrombophilia, genetic factors, anatomical abnormalities, endocrine issues, immune factors, and infections. It provides treatment recommendations for different conditions like administering low-dose aspirin and heparin for antiphospholipid syndrome. The effectiveness of progesterone supplementation is questioned based on recent clinical trial results. Surgical and medical management of conditions like chronic endometritis are outlined. The role of various diagnostic tests and treatments for interpreting RPL causes are also examined.
Progesterone, new values in clinical practiceMamdouh Sabry
- Progesterone is a steroid hormone that plays several important roles in the female reproductive system and pregnancy. It can be produced naturally in the body or taken as a synthetic progestin medication.
- There are two major progesterone receptor subtypes, PRA and PRB. PRA inhibits the effects of PRB and other steroid receptors in many tissues where they are expressed.
- Micronized natural progesterone from plant sources has fewer side effects than older synthetic progestins and more closely mimics the body's endogenous progesterone. It can be administered orally, vaginally, or through other routes.
- Progesterone supplementation shows benefits for preventing preterm birth and recurrent pregnancy loss according to some studies,
Dydrogesterone has higher bioavailability (up to 28%) compared to micronized progesterone (less than 10%), allowing it to be effective at a much lower dose of 10-30 mg/day versus 200-300 mg/day for micronized progesterone. Dydrogesterone also causes fewer adverse effects due to its minimal activation of non-progesterone receptors. While dydrogesterone has extensive clinical trial evidence and approvals for threatened miscarriage and progesterone deficiencies, micronized progesterone only has trials and approval for secondary amenorrhea.
This document discusses various methods of contraception, including natural methods, barrier methods, intrauterine devices, implants, injections, oral contraceptives, and emergency contraception. It provides details on the mechanisms of action, effectiveness, and side effects of different hormonal contraceptives containing progestins and/or estrogens, such as combined oral contraceptives, progestin-only pills, contraceptive patches, vaginal rings, and injectables. The document also discusses criteria for use and cautions for different contraceptive methods.
This document discusses various methods for inducing lactation in non-birth mothers, including the use of hormones, galactogogues (medications that increase milk production), herbal supplements, nipple stimulation, and breast pumps. It provides details on hormones involved in lactation, common galactogogues like metoclopramide and domperidone, herbal options like fenugreek and blessed thistle, and the importance of regular nipple stimulation to induce lactation.
Deck on current treatment approaches in endometriosis (PART II) Dr Jyoti AgAR...Lifecare Centre
Dydrogesterone is proposed as a new treatment for endometriosis. It effectively tackles chronic inflammation associated with endometriosis by reducing proinflammatory cytokines and increasing progesterone receptor expression. Clinical evidence shows that dydrogesterone provides symptomatic relief for endometriosis-related pain and improves quality of life. It also reduces the development of new endometriotic lesions and induces atrophy of ectopic endometrial tissue. Unlike other medications, dydrogesterone does not inhibit ovulation or require estrogen add-back therapy, and it may improve pregnancy outcomes for women with endometriosis.
This document discusses luteal phase support in assisted reproductive technology (ART) and recurrent miscarriages. It defines luteal phase defect (LPD) and notes there is no standardized diagnostic test. LPD can cause infertility and recurrent pregnancy loss. Progesterone supplementation is recommended for confirmed LPD, unexplained infertility, advanced maternal age, ART cycles, hyperprolactinemia, and recurrent miscarriages. Progesterone is the preferred drug for luteal phase support as it promotes endometrial development without luteolytic effects. Vaginal progesterone is as effective as intramuscular with fewer side effects and optimal timing and duration of support is from oocyte retrieval/IUI to 9 weeks of gestation.
This document discusses ways to reduce miscarriage rates. It begins by outlining the agenda and introducing progesterone and NIPGT (non-invasive preimplantation genetic testing) as potential approaches. It then discusses how progesterone has immunomodulatory properties and supports the luteal phase in ART cycles. Several studies are summarized that show progesterone supplementation can reduce miscarriage rates. NIPGT is introduced as a less invasive way to assess chromosomal defects in embryos compared to traditional PGT. The document concludes that while progesterone is effective for reducing miscarriage, more evidence is still needed to determine if NIPGT could help in cases of recurrent miscarriage, especially in older patients.
Ovulation induction protocols for unexplained infertility new advances 2019 f...Anu Test Tube Baby Centre
1) Ovulation induction is used to treat unexplained infertility, where no specific cause is identified after basic evaluation. It aims to stimulate ovulation and increase the number of mature follicles available for fertilization.
2) Common protocols for ovulation induction in unexplained infertility include oral medications like clomiphene citrate or letrozole, injectable gonadotropins alone or with GnRH analogues, and IUI with or without ovarian stimulation.
3) While ovulation induction and IUI can help some women with unexplained infertility conceive, success rates decline significantly with increasing female age. Younger patients may benefit from several treatment cycles but many guidelines recommend proceeding directly to IVF after a year if
1) The document reviews the use of GnRH agonists versus HCG for triggering final oocyte maturation in IVF/ICSI cycles using a GnRH antagonist protocol.
2) In fresh autologous cycles, GnRH agonist triggering was found to have lower live birth, ongoing pregnancy rates and higher miscarriage rates compared to HCG, but lower OHSS incidence.
3) In donor-recipient cycles, there was no difference in ongoing pregnancy or miscarriage rates between GnRH agonist and HCG triggering, but GnRH agonists reduced OHSS incidence. Modified luteal phase support strategies have shown mixed results in improving outcomes after GnRH agonist triggering.
My talk on Thyroid and Infertility in Jabalpur in Feb 2019. I have summarised the available evidence until 2019 in an easy to use flowchart and slides. It would be very useful for practicing Endocrinologists, Physicians and Obs-gyn.
Dr. Sunita Chandra is the Chairperson and Director of Rajendra Nagar Hospital & IVF Centre and Director of Morpheus Lucknow Fertility Centre. She has extensive training and experience in fertility and IVF in India and Germany. She has published research papers and book chapters on fertility-related topics. She has held several leadership roles in fertility-related organizations and has spoken at numerous national and international conferences. She has received several awards for her contributions to medicine and healthcare in Uttar Pradesh.
Letrozole is an aromatase inhibitor that is an effective alternative to clomiphene citrate for ovulation induction. It has several advantages over clomiphene citrate including oral administration, lower risk of multiple pregnancies and miscarriage, and no antiestrogenic effects on the endometrium or cervical mucus. Studies show letrozole results in higher ovulation and pregnancy rates compared to clomiphene citrate. When used as an adjuvant to gonadotropins, letrozole reduces gonadotropin dosage and improves outcomes. Letrozole may help improve IVF success rates in poor responders by enhancing follicular response to gonadotropins and lowering estrogen
Ovarian reserve refers to the reproductive potential left within a woman's two ovaries based on number and quality of eggs. Diminished ovarian reserve is the loss of normal reproductive potential in the ovaries due to a lower count or quality of the remaining eggs
Use Of Galactogogues In Initiating Or Augmenting Maternal Milk SupplyBiblioteca Virtual
The document discusses the use of galactogogues, or substances used to induce, maintain, or augment maternal milk production. It provides guidelines for using galactogogues, including evaluating other factors first and increasing breast emptying. The most well-studied galactogogues are metoclopramide and domperidone, which work through dopamine antagonism. Herbal galactogogues like fenugreek are also discussed. Close monitoring of both mother and infant is recommended when using any galactogogue.
This document discusses lactogogues, which are foods or medications that can increase milk production in lactating mothers. It begins by defining lactation and lactose insufficiency. It then describes various types of lactogogues, including the synthetic medications metoclopramide and domperidone, and herbal options like fenugreek, alfalfa, shatavari, and fennel. The document provides details on how these lactogogues work and their potential side effects. It concludes by summarizing a survey that found the most commonly used lactogogues were lactation cookies, brewer's yeast, and fenugreek, and that domperidone had the highest rate of reported
This document provides guidelines for using galactogogues (medications or substances that increase milk supply) in initiating or augmenting maternal milk production. It summarizes evidence on the use of pharmaceutical galactogogues like domperidone and metoclopramide. Domperidone has been shown to moderately increase milk production in studies of preterm infants, while metoclopramide studies found no difference in milk volumes compared to placebo. The risks of domperidone include increasing the QTc interval and potential for cardiac issues, especially in higher risk groups. Non-pharmaceutical options and ensuring proper milk removal should be emphasized before considering galactogogues.
Nausea and vomiting of pregnancy 안계형 전임의mothersafe
Nausea and vomiting of pregnancy (NVP), also known as morning sickness, affects 80% of pregnant women. It peaks between 7-12 weeks of gestation and usually resolves by 16 weeks. In severe cases it is called hyperemesis gravidarum. While the exact cause is unclear, elevated hormone levels are thought to play a role. NVP is usually harmless but hyperemesis can lead to nutritional deficiencies and other complications if not treated. The combination of doxylamine and pyridoxine is the only FDA-approved treatment and studies show it is effective in reducing symptoms with no increased risk of adverse fetal outcomes when used as directed. Higher than standard doses may also be used safely if
This document provides guidelines from The Academy of Breastfeeding Medicine on the use of galactogogues, or substances used to increase milk production. It finds that while galactogogues can increase prolactin levels, there is no evidence they directly increase milk volumes. Studies of pharmaceutical galactogogues are inconclusive due to poor study quality. Herbal galactogogues also lack high-quality evidence. The guidelines emphasize optimizing breastfeeding practices through frequent feeding before considering galactogogues, which should only be used after discussing risks and benefits with a healthcare provider.
Emergency contraception, Combination Birth Control Pill, Progestogen-Only Pillsmaria may dizon
This document discusses different types of emergency contraception and birth control methods including combination birth control pills and progestogen-only pills. It provides information on how each method works, effectiveness rates, benefits and risks, side effects, drug interactions, complications and important considerations for patient education. The methods discussed are levonorgestrel, ulipristal acetate, combination birth control pills containing estrogen and progestin, and progestogen-only pills.
This document provides guidelines for healthcare providers on the management of diabetes in pregnancy. It recommends screening and diagnosing diabetes during pregnancy through oral glucose tolerance tests. It provides guidance on treating pre-existing diabetes and gestational diabetes through medical nutrition therapy, metformin, and insulin if needed. It also offers recommendations on fetal surveillance, timing and mode of delivery, and postpartum screening based on the type of diabetes and glycemic control. Algorithms provide guidance on initiating insulin therapy and managing blood glucose levels during labor and delivery.
This document provides information on hormonal contraception, including combined oral contraceptive pills and progestogen-only pills. It discusses the types of combined and progestogen-only pills, their effectiveness, mode of action, use guidelines, side effects, advantages, and contraindications. Combined oral contraceptive pills are very effective at preventing pregnancy when taken correctly, with a failure rate of less than 1% with perfect use. Progestogen-only pills are effective options for breastfeeding women and those who cannot use estrogen. Altered bleeding is a common side effect of progestogen-only pills.
Family Planning & Contraception discusses various contraceptive methods including natural/fertility awareness methods like the Standard Days Method and Calendar Rhythm Method, as well as artificial/hormonal methods like combined oral contraceptive pills and progestin-only pills. The document outlines the goals of family planning to enable couples to choose family size and birth timing safely and effectively. It also discusses the roles and responsibilities of medical experts to provide harm-free contraception information and options.
This document provides information on different types of oral contraceptives and how they work. It discusses combined oral contraceptives (COCs) which contain both estrogen and progesterone. COCs prevent ovulation and make implantation less likely. Their effectiveness depends on correct and consistent use. Side effects may include changes in bleeding patterns and headaches. It also discusses progestin-only pills (POPs) which contain progesterone only and work mainly by thickening cervical mucus. Injectable contraceptives like DMPA are administered through injection and provide contraception for 1-3 months by inhibiting ovulation. Implants are long-acting reversible methods involving rods inserted under the skin that release progestin.
This document provides information on different types of oral contraceptives and how they work. It discusses combined oral contraceptives (COCs) which contain both estrogen and progesterone. COCs prevent ovulation and make implantation less likely. Their effectiveness depends on correct and consistent use. Side effects may include changes in bleeding patterns and headaches. It also discusses progestin-only pills (POPs) which contain progesterone only and work mainly by thickening cervical mucus. Injectable contraceptives like DMPA are administered through injection and provide contraception for 1-3 months by inhibiting ovulation. Implants are long-acting reversible methods involving rods inserted under the skin that release progestin and prevent pregnancy for 3-5
This document discusses induction of labor, including common indications and contraindications, available methods, and risks. Some key points:
- Induction of labor is indicated when benefits of delivery outweigh continuing pregnancy, for maternal or fetal reasons like post-term pregnancy or fetal anomaly.
- Methods include mechanical (balloon catheters), chemical (prostaglandins like misoprostol, dinoprostone), and oxytocin. Choice depends on cervical status using the Bishop score.
- Risks include failed induction requiring C-section, uterine hyperstimulation, fetal distress. Careful patient selection and monitoring during induction are important.
This presentation is made by taking help from RCOG Guideline about Obstetric Cholestasis.
To watch video about this presentation visit this YouTube link.
https://www.youtube.com/watch?v=gD7bN6zaLJU
This document covers therapeutic considerations related to pregnancy, lactation, and breastfeeding. It discusses changes in pharmacokinetics during pregnancy and outlines principles for drug selection. Common conditions in pregnancy like nausea/vomiting and hypertension are addressed. Teratogenic risks of medications are categorized by the FDA. Labor/delivery issues like preterm labor and induction are also covered. The document provides guidance on managing chronic conditions and breastfeeding safety based on infant drug exposure factors.
1. Tight glycemic control through medical nutrition therapy, exercise, blood glucose monitoring, and potentially insulin is important to manage diabetes in pregnancy.
2. Close fetal surveillance through growth scans and tests are needed to monitor for complications like macrosomia.
3. Delivery timing and type (vaginal vs c-section) depends on maternal and fetal status and risks like macrosomia.
4. Neonatal risks include hypoglycemia, jaundice, and respiratory distress which requires close monitoring after birth.
5. Counseling on future diabetes risk and appropriate contraception is important in postpartum care.
Progesterone is a natural hormone that prepares the uterus for pregnancy and helps maintain pregnancy. It can be produced naturally by the body or synthesized for medical uses. Progesterone has physiological actions in the uterus, cervix, vagina, breasts, central nervous system, and elsewhere to support pregnancy. It works by binding to progesterone receptors and regulating gene transcription. Progesterone and progestins are used for contraception, hormone replacement therapy, dysfunctional uterine bleeding, threatened miscarriage, endometriosis, and other conditions. Common side effects include changes in menstruation, headaches, and breast tenderness.
Prolactin enhances breast development during pregnancy and induces lactation. It is produced in the pituitary gland and its levels are normally inhibited by dopamine. Prolactin levels may be elevated in conditions like prolactinomas or certain drugs. Hyperprolactinemia can cause symptoms like menstrual irregularities, infertility, and galactorrhea. Prolactinomas are treated initially with dopamine agonists like cabergoline, which lower prolactin levels by activating D2 receptors on lactotroph cells. Cabergoline is more potent and long-acting than bromocriptine, making it a preferred treatment for conditions involving elevated prolactin levels.
Pregestational diabetes a major obstetrical problem now a days. These PPT contains modern as well as Ayurveda aspect for preventing a pregnant women & her baby from developing complications.
It describes the Progesterone physiology. It describes the latest evidence as regards progesterone formulations, use of progesterone as Luteal phase support. It scrutinizes the value of serum progesterone in monitoring luteal phase
CME INDUCED LACTATION focused on counseling skills, breastfeeding starting out right, pumping instruction, and increasing milk supply. The document provided an overview on lactation counseling for increasing milk supply through proper breastfeeding techniques, pumping, and nutrition.
Borang pemantauan penjualan makanan dan minuman kss1a 2018JessWongHuiJuan1
Borang ini digunakan untuk memantau penjualan makanan dan minuman di kantin sekolah. Ia menilai kepatuhan kantin terhadap garis panduan kesihatan dengan menilai jenis makanan yang dijual, kehadiran sayuran dan buah-buahan, serta tahap lemak dalam makanan. Borang ini perlu diisi oleh pegawai kesihatan dan ditandatangani oleh kedua-dua pihak sekolah dan pegawai untuk mengesahkan hasil pemant
Pemakanan untuk guru pra sekolah dan pembantu pra sekolahJessWongHuiJuan1
Modul ini memberi panduan kepada PPM/Pekerja Sambilan Harian tentang penyediaan makanan yang sihat dan berkhasiat untuk kanak-kanak prasekolah. Ia menekankan pentingnya memenuhi keperluan pemakanan kanak-kanak, menggunakan kaedah memasak yang sihat, dan mematuhi amalan kebersihan dan keselamatan makanan."
Breastfeeding and nutrition by jess wong hui juan 05022017JessWongHuiJuan1
This document discusses breastfeeding and provides information on:
- The benefits of breastfeeding for babies including ideal nutrition, protection from infections, reduced risks of various health conditions.
- The importance of skin-to-skin contact immediately after birth, early initiation of breastfeeding within the first hour of life, and rooming-in 24/7 for establishing breastfeeding and bonding.
- The importance of feeding on demand and frequently to ensure babies receive enough milk and the milk supply is well established.
Power of nutrition for the first 1000 days by jess 06082016 slideshareJessWongHuiJuan1
The document is a presentation by Wong Hui Juan on nutrition in the first 1000 days of life. It covers topics like the importance of nutrition during pregnancy, lactation, and complementary feeding. It discusses recommendations for introducing solid foods at 6 months, appropriate food textures and amounts as the baby grows. The presentation provides information on meeting nutrient needs and establishing healthy eating habits. It also addresses common concerns parents have around feeding such as poor appetite, food allergies and illness.
Dokumen tersebut membahasakan pentingnya penyusuan susu ibu, pengendalian susu ibu di TASKA, dan cara memberikan susu dengan botol yang aman dan benar. Ia menjelaskan manfaat susu ibu, kebijakan penyusuan di Malaysia, cara menyimpan dan memanaskan kembali susu ibu, serta fasilitas yang dibutuhkan untuk mendukung ibu menyusui di TASKA. Dokumen ini juga memberikan panduan lengkap tentang pembersi
Borang ini digunakan untuk memantau penjualan makanan dan minuman di kantin sekolah. Ia menilai pematuhan penjualan terhadap garis panduan kesihatan dengan memberi markah demerit untuk item-item yang tidak memenuhi standard. Borang ini perlu diisi oleh pegawai kesihatan dengan menandakan 'x' pada item-item yang tidak sesuai dan mengira peratus pematuhan berdasarkan jumlah markah. Laporan dan tindakan susulan per
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
Letter to MREC - application to conduct studyAzreen Aj
Application to conduct study on research title 'Awareness and knowledge of oral cancer and precancer among dental outpatient in Klinik Pergigian Merlimau, Melaka'
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)blessyjannu21
Neurological system includes brain and spinal cord. It plays an important role in functioning of our body. Encephalitis is the inflammation of the brain. Causes include viral infections, infections from insect bites or an autoimmune reaction that affects the brain. It can be life-threatening or cause long-term complications. Treatment varies, but most people require hospitalization so they can receive intensive treatment, including life support.
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyR3 Stem Cell
Dr. David Greene, founder and CEO of R3 Stem Cell, is at the forefront of groundbreaking research in the field of cardiology, focusing on the transformative potential of stem cell therapy. His latest work emphasizes innovative approaches to treating heart disease, aiming to repair damaged heart tissue and improve heart function through the use of advanced stem cell techniques. This research promises not only to enhance the quality of life for patients with chronic heart conditions but also to pave the way for new, more effective treatments. Dr. Greene's work is notable for its focus on safety, efficacy, and the potential to significantly reduce the need for invasive surgeries and long-term medication, positioning stem cell therapy as a key player in the future of cardiac care.
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
At Apollo Hospital, Lucknow, U.P., we provide specialized care for children experiencing dehydration and other symptoms. We also offer NICU & PICU Ambulance Facility Services. Consult our expert today for the best pediatric emergency care.
For More Details:
Map: https://cutt.ly/BwCeflYo
Name: Apollo Hospital
Address: Singar Nagar, LDA Colony, Lucknow, Uttar Pradesh 226012
Phone: 08429021957
Opening Hours: 24X7
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Gemma Wean- Nutritional solution for Artemiasmuskaan0008
GEMMA Wean is a high end larval co-feeding and weaning diet aimed at Artemia optimisation and is fortified with a high level of proteins and phospholipids. GEMMA Wean provides the early weaned juveniles with dedicated fish nutrition and is an ideal follow on from GEMMA Micro or Artemia.
GEMMA Wean has an optimised nutritional balance and physical quality so that it flows more freely and spreads readily on the water surface. The balance of phospholipid classes to- gether with the production technology based on a low temperature extrusion process improve the physical aspect of the pellets while still retaining the high phospholipid content.
GEMMA Wean is available in 0.1mm, 0.2mm and 0.3mm. There is also a 0.5mm micro-pellet, GEMMA Wean Diamond, which covers the early nursery stage from post-weaning to pre-growing.
2. Overview
• Induced lactation from islamic perspectives
• Protocols
• Effect of galactagogues
• Supplementary feeding devices
3. Induced lactation from islamic
perspectives
• Muzakarah- 96 (2011)
– Islam membenarkan wanita yang tidak melahirkan
anak tetapi mengambil anak angkat menyusukan
sendiri anak tersebut dengan bantuan perubatan
– Pandangan jumhur ulamak, hambali, Syafi’e dan
Hanafi yg menyatakan seorang perempuan yang
hendak menyusukan tidak diisyaratkan
mempunyai suami
– Penggunaan ubtan dan suntikan utk merangsang
pengeluaran susu adalah harus
4. Tujuan dan matlamat penyusuan Ibu
Pemakanan
bayi
Susu ibu yg
terbaik
Untuk 6 bulan
secara eksklusif
Diteruskan
sehingga 2 tahun
Hubungan
Status Mahram
5 kali penyusuan
Susu yang dihisap
mestilah sampai
ke perut bayi
Umur bayi tidak
lebih 2 tahun
(qamariah)
5.
6. The Newman Goldfarb Protocol
• Developed in 1999
• For surrogacy or adoptive mother
• Medications and pumping
• Reduces the need for supplementation
• Derived from Lenore’s own experience with
induced lactation and that of 500 women that
she and Dr Newman have followed
7. Effect of hormones on breast
• Estrogen: stimulates the ductal epithelial cells
• Progesterones: induced duct formation
• Prolactin: complete lobulo-alveolar
development. It stimulates milk production
• Oxytocin: milk ejection reflex
• Human placenta lactogen, growth factor,
insulin etc
9. Regular protocol
• The longer the mother can be on her
particular protocol, the more milk she will end
up with
• For surrogacy or adoptive mothers with a long
lead time
• Six months and longer
10. • 1 week: COCP each day + 10mg domperidone 4x/day
• 2nd week till 6months: continuous COCP and
domperidone 20mg 4x/day
• Alternatives: T. provera 2.5mg OD/ T. prometrium
100mg OD
• Stop COCP and continue with domperidone 6weeks
before baby is due
• No pumping or herbs until 6weeks before the baby is
due
• Slowly decrease the domperidone once mother’s milk
supply is well established
11. Accelerated protocol
• Suitable for adoptive mother or intended
mothers who have little time to prepare , or
for mothers who wish to relactate
• Milk production may be significantly lower
12. • COCP + domperidone 20mg QID for 30-60
days
• Alternative: t. provera
• If significant breast changes occur within 30
days, stops the birth control pill while
maintaining the domperidone and pumping
schedule begins
• Significant breast changes: increased in breast
size and feel full, heavy and painful
13. Menopause protocol
• Menopausal d/t surgical removal of her
reproductive organs or naturally occuring
menopause
• A women does not need a uterus or ovaries in
order to breastfeed
• Breasts and functioning pituitary
14. • COCP + domperidone 20mg QID for 30-60
days
• Alternative: t. provera
• If significant breast changes occur within 30
days, stops the birth control pill while
maintaining the domperidone and pumping
schedule begins
• Significant breast changes: increased in breast
size and feel full, heavy and painful
15. What to do if the mother does not
experince significant breast changes
• If not significant changes after 15 days-
Consider to increase progesterone intake
• Yasmin ( 3 times the amount of progesterone )
• Microgestin ( third more progesterone than in
the 1/35 pills)
• Adding T. provera 1.25mg
17. What supportsOptimal lactation?
Normal breast anatomy
Intact neuroendocrine reflex
Good general health and
nutritional status
Effective support system
19. Neuroendocrine Reflex
Therelease and production of prolactin isdependent
onthe inhibition of a factor
Prolactin inhibitor factor,
produced by the hypothalamus,and dopamine-releasing
neurons.
Activation of dopamine receptors onprolactin-secreting
cellsinhibits the release of prolactin.
Prolactin regulates the volumeof milk produced
Oncelactation isestablished
infant demand drives the process.
Inthe absenceof suckling,lactation ceasesin 2 to 3 week
20. NutritionDuring Lactation
No special food or drinks
Generally healthy well balanced diet
Drink fluids to thirst
Adequate protein and calories
*Calcium
*Multivitamin supplement
22. What are Galactogogues?
Substancethat aid in initiating and
maintaining adequate milk production.
FromGreekword:
Galact - Milk
Agogos - Leading
2 broad categories:
Synthetic
Herbal/Natural
23. Mechanismof action
Poorly understood, inherentdifficulties of
researching
Mostexert their pharmacologic effects through
interactions with dopamine receptors
increased prolactin levels
augmenting milk supply
24. Isthere a role?
May be usefulfor womenwhoare unable to
produce breast milk ontheir owndueto:
infant prematurity
Illness of themotheror child,
adoption, or
surrogate motherhood.
25. PointstoConsider
Thereare manyreasonswhy a mother’smilk supply
might be low.
Need to evaluate and address underlying factors
TheAcademy of Breastfeeding Medicine protocol on
galactogogues says:
Prior to the useof a galactogogue
thoroughevaluation shouldbe performed of the entire
feeding processby a lactation expert.
Reassurancemaybe offered, if appropriate.
When intervention isindicated, modifiable factors
shouldbeaddressed
26. Modifiable factors
Medication shouldnever replace evaluation and
counselingonmodifiable factors
comfort and relaxation for the mother,
frequency and thoroughnessof milk removal
correcting positioning and attachment
correcting suckling difficulties
expressing milk after feedings to
increase supply
underlying medical conditions.
28. Metoclopramide
majority of published clinical data evaluating the useof
drug therapy for breast milk production
promoteslactation by antagonizing the release of
dopamine in the central nervous system.
Alsostimulates the upper gastrointestinal tract through a
similar mechanism
Indication:
symptomatic treatment of gastroesophageal reflux
diabetic gastroparesis, and
prevention and treatment of nauseaand vomiting
associated with pregnancy, chemotherapy and postsurgical
situations
29. Metoclopramide
Doseresponserelationship for improved lactation
Daily dosesof 30 and 45 mgof metoclopramide resulted in
significant increasesin serumprolactin levels and milk yield,
45 mgdaily doseproduce a faster onsetof effect
Effective and safe therapy for the initiation and
maintenanceof lactation: 10 mgorally 3 timesaday
Maternal side effects observed during therapy:
diarrhea and nervousness
Cancauseextrapyramidal sideeffects
Remainsasthe galactogogue of choice
due to its documentedrecord of efficacy
and safety in womenand infants.
30. Domperidone
also a dopamine antagonist
Indication: treatment of chronicpostprandial
dyspepsia, reflux esophagitis, and emesis
Dosesusedfor inductionand maintenanceof
lactation:
10 to 30 mg3 timesdaily
exerts pharmacologic effects in
the periphery rather than centrally
31. Domperidone
RCTshowseffective and safe methodof inducing
lactation during short-term use
lesslipid soluble,hasa larger molecularweight
and haslower protein binding
limited amountof the drug crossesthe blood-
brain barrier
reduced extrapyramidal side
effects.
Decreasedrisk of toxicity to
both motherandinfant
anattractive alternative
32. Other drugs
Traditional antipsychotics:
sulpiride andchlorpromazine
Humangrowthhormone
thyrotrophin-releasing hormone
Oxytocin
adverse eventslimit their use.
33. Natural Galactogogues
Herbs
Culinary
Non Culinary
Little researchonmostcommon
herbal preps
Animal vsHumanstudies
In vitro vsin vivo studies
Mostare anecdotalreports
34. Natural Galactogogues
Almostevery culture hassomesort of herb or plant or
potion to increasemilk supply
Quite possible that herbal remedies help increase
milk supply.
someplants and herbsmight contain similar
pharmacological agentsasdrugs
that increasemilk supply
Note that evenherbscanhave
side effects, evenserious ones.
36. Fenugreek
Mostanecdotal useof the herb in at
least 1200 women
Anecdotal reports of the successfuluse
asa galactogogue havebeen
documentedasfar back as1945.
Formalpublished clinical data lacking
doseasa galactogogue: 2 to 3 capsules3 times
daily (Max: 6g/dy)
Theamountof fenugreek in eachcapsulemayvary
from batch to batch
37. Fenugreek
Specific mechanismof action unknown
may affect breast milk production by stimulating sweat
production, and the breast isa modified sweat gland
Somereported adverseevents
maple-like odor to urine and sweat
Diarrhea
aggravation of asthmatic symptoms.
Contraindicated in pregnancy due to
uterostimulant effects
39. Reasonswhy should notberoutine advice
1.May cause side effects for mother,baby, or both.
for example: Fenugreek
caninterfere with the absorption of medication,
vitamins,minerals, etc., whichcould evenworsenthe
underlying factors
cancausehypoglycaemia
cancauseGI upsetin baby and mother
thosewhohaveallergies to other legumes,suchas
peanuts,mayexperience cross-reactions
41. Reasonswhy should notberoutineadvice
3.Galactogogues cost money and time
Mostpricesare marked-up e,g “lactation cookie”
Herbal preps mustbe sourced
time would be better spenton
an extra nursingsessionor some
self-care
42. Reasonswhy should notberoutineadvice
3.Suggesting use of galactogogues reinforces the
idea thatspecial food is needed for breastfeeding
underminesa mother’sconfidence in her ability to
breastfeed.
Need to reinforce:
breastfeeding isthe normal way to
feed a human baby,
nospecial gadgets or diets required.
44. SNS – REASONS &INDICATIONS
• At initial phase of induced lactation program
- Stimulation
- Toensure baby able to latch on the breast
(baby know that milk ispresent)
- Toensure baby feeling satiety
- Prevent nipple confusion
- BONDING
45. • At maintenance phase (after milk has been produced)
- Maintain stimulation
- Adherence to the breast
- Prevent breast rejection / refusal
- Maintain BONDING
- Prevent blocked ducts
- Toensure successful milk production – adequate &
achievement of MAHRAM status
SNS – REASONS &INDICATIONS
49. FEEDING ON SNS :
TIME MANAGEMENT
CAN FEED ANYWHERE
& ANYTIME
PROPER PREPARATION
50. PSYCHOLOGICAL
• NEW MOTHERS – UNABLE TO COPE WITH BABY’s BEHAVIOUR
(CRYING, SLEEPING & etc) & HOUSEHOLD CHORES
• MOTHER - ANXIETY & STRESSFUL
• NOT MENTALLY PREPARED TO BE A MOTHER
• NON SUPPORTIVE SPOUSE & FAMILY MEMBERS
• TIME CONSUME FOR PREPARING SNS EQUIPMENTS LONGER
THAN PREPARATION OF BOTTLE FEEDING
• NOT ENOUGH TIME – TO PUMP & USING SNS
• WORKING MOTHER - NOT CONDUCIVE WORKPLACE
ANTICIPATINGPROBLEMS
51. ANTICIPATINGPROBLEMS
DEVICES – SNS EQUIPMENTS
• BLOCKED TUBES
• TUBES – BROKEN
• PREPARING SNS – SIMILAR TO COMPLETE THE PUZZLE OF
MULTIPLE PARTS - INCORRECT & CONSUME LOTS OF TIMES
• MAINTAINING HYGIENE, STERILITY & CLEANING PROCESS
• BABY REJECTION – FEELING UNCOMFORTABLE WITH THE
PRESENCE OF TUBE
• BABY POSITION – MAY PULL THE TUBE / KINKING THE TUBE
52. SUPPLEMENTARY FEEDINGDEVICES
• COUNSELORS & MOTHERS NEED TO FAMILIARIZE WITH THE
DEVICE COMPONENTS
• NEED TO KEEP PRACTICE ON HOW TO USE & HANDLE SNS
• MAY NEED MORE DEVICES OR EMERGENCY PLAN (QUICK
DEVICES)
• DEVICES – CARE & HYGIENE
• TIME MANAGEMENT
• TECHNIQUE OF LATCHING ON THE BREAST WITH SNS TUBE
• PATIENCE & PASSION